INDIA IPO
  • Home
  • About
    • About us
    • Our CSR
  • Services

    IPO

    • Initial Public Offering (IPO)
    • SME IPO Consultation
    • Mainline IPO Consultation
    • Follow-On Public Offer (FPO)
    • Pre-IPO Funding Consultants

    Capital Raising

    • Social Stock Exchange
    • Private Placement
    • Project Funding
    • REIT
    • SM REIT
    • Rights Issue Advisory
    • InvIT Rights Issue
    • InvIT Public Issue
    • InvIT Private Issue
    • Debt Syndication
    • Securitised Debt Instruments
    • Public Municipal Debt
    • Private Municipal Debt

    Finance Advisory

    • Business Valuation
    • Corporate Finance
    • Financial Modelling
    • Project Finance
  • Investors
  • Merchant Bankers

    SME

    • List of SME Merchant Bankers

    MAINBOARD

    • List of Mainboard Merchant Bankers
  • Resources

    Reports

    • Daily Reporter
    • IPO Calendar
    • Mainline IPO Report
    • SME IPO Report
    • SME IPOs by Sector
    • Mainboard IPOs by Sector

    IPO Knowledge

    • IPO World Magazine
    • IPO Process
    • Pre-IPO Process Guidance
    • IPO Blogs
    • Sector Wise IPO List In India
    • List of IPO Registrar

    Notifications / Circulars

    • BSE SME Eligibility Criteria
    • SEBI ICDR Amendment Regulations March 2025
    • SEBI SME IPO ICDR Amendments report Mar–Nov 2025
    • NSE Emerge Eligibility Criteria
    • ICDR
  • News/Updates
    • Markets & Money Update
    • IPO & Market Snaps
  • Contact Us
  • Check IPO Feasibility
Check IPO Feasibility
INDIA IPO
INDIA IPO

Contact Info:

  • +91-96506-37280
  • +011-47008280
  • info@indiaipo.in
  • 808, 8thFloor D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034.
shape
  1. Home
  2. News
  3. Max Healthcare Institute Allots 51,287 Equity Shares Under Employee Stock Option Scheme
ipo services in India
India IPO
  • 01 May 2026
  • X
 Max Healthcare Institute Allots 51,287 Equity Shares Under Employee Stock Option Scheme

Max Healthcare Institute Limited allotted 51,287 equity shares to employees under its Employee Stock Option Scheme 2022 on May 1, 2026. The shares were issued at ₹350 per share with a ₹340 premium, increasing the company's paid-up capital to ₹973.24 crores. The allotment was approved by the Nomination & Remuneration Committee and complies with SEBI regulations, with the newly issued shares being identical to existing equity shares.

Max Healthcare Institute Allots 51,287 Equity Shares Under Employee Stock Option Scheme

Max Healthcare Institute Limited has completed the allotment of 51,287 equity shares to eligible employees under its Employee Stock Option Scheme 2022. The Nomination & Remuneration Committee approved this allotment on May 1, 2026, at 6:56 pm IST, as part of the company's employee incentive program.

Share Allotment Details

The allotment involves 51,287 equity shares with a face value of ₹10 each, issued as fully paid-up shares to eligible employees who exercised their vested stock options. The exercise price was set at ₹350 per equity share, with a premium of ₹340 per share.

Allotment Parameters: Details Number of Shares: 51,287 equity shares Face Value: ₹10 per share Exercise Price: ₹350 per share Premium: ₹340 per share Allotment Date: May 1, 2026

Impact on Share Capital

The allotment has resulted in an increase in the company's paid-up equity share capital. The shares have been issued in dematerialized form with distinctive numbers ranging from 97,31,92,503 to 97,32,43,789.

Capital Structure: Pre-allotment Post-allotment Number of Equity Shares: 97,31,92,502 97,32,43,789 Face Value: ₹10 ₹10 Paid-up Equity Capital: ₹973,19,25,020 ₹973,24,37,890

Regulatory Compliance

The allotment has been made in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company filed the initial statement under regulation 10(b) with the stock exchanges on September 29, 2022, receiving filing numbers DCS/IPO/MJ/ESOP-IP/2511/2022-23 from BSE and NSE/LIST/32765 from NSE.

Share Characteristics

The newly allotted equity shares are identical in all respects to the existing equity shares of the company. No lock-in provisions apply to these shares, and no listing fees are payable for this allotment. The company has noted that this allotment is not material in nature under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The disclosure regarding this allotment will be hosted on the company's website at www.maxhealthcare.in , ensuring transparency and compliance with regulatory requirements.

Max Healthcare Institute Limited has received a significant relief in the form of a GST rectification order that withdraws the entire demand of ₹55,20,45,266 raised against the company. The rectification order was issued on April 21, 2026, by the Office of the GST Officer, Ward 96, Zone 9, Department of Trade and Taxes, New Delhi, and was received by the company on the same day at 12:27 PM IST.

GST Demand Withdrawal Details

The rectification order represents a complete reversal of the earlier GST demand that was raised against Max Healthcare Institute. The company has provided detailed disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Parameter Details Order Date April 21, 2026 Demand Amount Withdrawn ₹55,20,45,266 Issuing Authority GST Officer, Ward 96, Zone 9, Department of Trade and Taxes Location 9th Floor, Vyapar Bhawan, I.P. Estate, New Delhi Receipt Time April 21, 2026 at 12:27 PM IST

Background and Resolution

This development follows the company's earlier intimation dated December 30, 2025, wherein Max Healthcare Institute had informed about receiving an order from the Office of the GST Officer alleging excess availment of Input Tax Credit. The original order was issued by Ward-92&96, Department of Trade and Taxes, GNCT of Delhi.

Upon due consideration of the submissions made by the company, the GST authority accepted the rectification application filed by Max Healthcare Institute. The authority's decision to withdraw the entire demand indicates that the company's submissions were found to be satisfactory and compliant with GST regulations.

Regulatory Compliance

The company has fulfilled its disclosure obligations by informing both the National Stock Exchange of India Limited and BSE Limited about this development. The disclosure has also been hosted on the company's website at www.maxhealthcare.in as part of its transparency commitments.

Exchange Symbol/Code National Stock Exchange MAXHEALTH BSE Limited 543220

The rectification order represents a positive outcome for Max Healthcare Institute, eliminating a significant financial liability that was previously under dispute. The company's proactive approach in filing the rectification application and providing necessary submissions to the GST authorities has resulted in the complete withdrawal of the demand.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

Recent News

National Peroxide Limited Reports Mixed Financial Performance for Q4 FY26
National Peroxide Limited Reports Mixed Financial Performanc...
01 May 2026
India Shelter Finance Corporation Allots 6,400 Equity Shares Under ESOP Schemes
India Shelter Finance Corporation Allots 6,400 Equity Shares...
01 May 2026
Vedant Fashions Limited Schedules Board Meeting for May 8, 2026 to Approve Q4 FY26 Results
Vedant Fashions Limited Schedules Board Meeting for May 8, 2...
01 May 2026
VPRPL Board Approves Fund Raising of Up to INR 300 Crores Through Equity Instruments
VPRPL Board Approves Fund Raising of Up to INR 300 Crores Th...
01 May 2026
RBI should reject Tata Sons application to deregister as a CIC: InGovern Research
RBI should reject Tata Sons application to deregister as a C...
01 May 2026
Mold-Tek Technologies Limited Withdraws Preferential Issue of 2,90,000 Equity Shares
Mold-Tek Technologies Limited Withdraws Preferential Issue o...
01 May 2026
Meghmani Organics Receives NCLT Order for Amalgamation Scheme Meetings on June 06, 2026
Meghmani Organics Receives NCLT Order for Amalgamation Schem...
01 May 2026
$15 Billion space bet: SpaceX’s ‘Starship’ spend dwarfs Falcon as IPO horizon nears – Report
$15 Billion space bet: SpaceX’s ‘Starship’ spend dwarfs Falc...
01 May 2026
Mangalam Global Enterprise Receives In-Principle Approval for ESOP Listing of 33,00,000 Equity Shares
Mangalam Global Enterprise Receives In-Principle Approval fo...
01 May 2026
Jyoti Resins and Adhesives Limited Schedules Board Meeting for Q4FY26 Results on May 7, 2026
Jyoti Resins and Adhesives Limited Schedules Board Meeting f...
01 May 2026
pre ipo advisory services in India
  • GST No: 07AAHCB7068H2ZF

India IPO is a leading Indian business services platform that helps firms and companies to launch their initial public offerings (IPOs) in order to raise essential capital for growth and expansion while adding value & fueling the nation’s immense potential and future opportunities.

Follow us:

Facebook Twitter LinkedIn Instagram YouTube

Quick Links

  • Home
  • Blogs
  • Consultant
  • Youtube Videos
  • News
  • Contact Us
  • Career

Contact Information:

  • Corporate Office: 808, 8th Floor, D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034
  • Regional Office: Office No. 601, Shagun Insignia, Ulwe, Sector-19, Navi Mumbai- 410206
  • Email: info@indiaipo.in
  • Mobile: +91-74283-37280, +91-96509-82781
  • Disclaimer  |
  • Privacy & Policy  |
  • Terms & Conditions  

Copyright © All rights reserved by - Bmarkt Tecamat Private Limited